100 related articles for article (PubMed ID: 9274933)
1. Stimulus dependence of non-steroidal antiinflammatory drug potency in a cellular assay of prostaglandin H synthase-2.
Hulkower KI; Otis ER; Wernimont AK; Bell RL
Eur J Pharmacol; 1997 Jul; 331(1):79-85. PubMed ID: 9274933
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin H synthase-2 inhibitors interfere with prostaglandin H synthase-1 inhibition by nonsteroidal anti-inflammatory drugs.
Rosenstock M; Danon A; Rubin M; Rimon G
Eur J Pharmacol; 2001 Jan; 412(1):101-8. PubMed ID: 11166741
[TBL] [Abstract][Full Text] [Related]
3. On the interaction of specific prostaglandin H synthase-2 inhibitors with prostaglandin H synthase-1.
Burde T; Rimon G
Eur J Pharmacol; 2002 Oct; 453(2-3):167-73. PubMed ID: 12398900
[TBL] [Abstract][Full Text] [Related]
4. Induction of prostaglandin H synthase-2 and tumor necrosis factor-alpha in human amnionic WISH cells by various stimuli occurs through distinct intracellular mechanisms.
Hulkower KI; Otis ER; Li J; Ennis BW; Cugier DJ; Bell RL; Carter GW; Glaser KB
J Pharmacol Exp Ther; 1997 Feb; 280(2):1065-74. PubMed ID: 9023325
[TBL] [Abstract][Full Text] [Related]
5. Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4-difluorothio-phenyl)-1-inda none (L-745,337), on the cyclo-oxygenase activity of human blood prostaglandin endoperoxide synthases.
Panara MR; Greco A; Santini G; Sciulli MG; Rotondo MT; Padovano R; di Giamberardino M; Cipollone F; Cuccurullo F; Patrono C
Br J Pharmacol; 1995 Nov; 116(5):2429-34. PubMed ID: 8581280
[TBL] [Abstract][Full Text] [Related]
6. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
[TBL] [Abstract][Full Text] [Related]
7. NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions.
Futaki N; Yoshikawa K; Hamasaka Y; Arai I; Higuchi S; Iizuka H; Otomo S
Gen Pharmacol; 1993 Jan; 24(1):105-10. PubMed ID: 8482483
[TBL] [Abstract][Full Text] [Related]
8. PGHS-2 inhibitors, NS-398 and DuP-697, attenuate the inhibition of PGHS-1 by aspirin and indomethacin without altering its activity.
Rosenstock M; Danon A; Rimon G
Biochim Biophys Acta; 1999 Aug; 1440(1):127-37. PubMed ID: 10477832
[TBL] [Abstract][Full Text] [Related]
9. Regulation of prostaglandin production in an immortalized human myometrial cell line by cytokines and non-steroidal anti-inflammatory drugs.
Sato TA; Keelan JA; Mitchell MD
Eur J Obstet Gynecol Reprod Biol; 2002 Jan; 100(2):158-62. PubMed ID: 11750956
[TBL] [Abstract][Full Text] [Related]
10. Effects of nimesulide on constitutive and inducible prostanoid biosynthesis in human beings.
Panara MR; Padovano R; Sciulli MG; Santini G; Renda G; Rotondo MT; Pace A; Patrono C; Patrignani P
Clin Pharmacol Ther; 1998 Jun; 63(6):672-81. PubMed ID: 9663182
[TBL] [Abstract][Full Text] [Related]
11. Involvement of cyclooxygenase-2 in interleukin-1alpha-induced prostaglandin production by human periodontal ligament cells.
Noguchi K; Shitashige M; Ishikawa I
J Periodontol; 1999 Aug; 70(8):902-8. PubMed ID: 10476899
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
13. Differential inhibition of murine prostaglandin synthase-1 and -2 by nonsteroidal anti-inflammatory drugs using exogenous and endogenous sources of arachidonic acid.
Chulada PC; Langenbach R
J Pharmacol Exp Ther; 1997 Feb; 280(2):606-13. PubMed ID: 9023270
[TBL] [Abstract][Full Text] [Related]
14. Effects of non-steroidal anti-inflammatory drugs and cyclooxygenase-2 specific inhibitors on mediator release from rat peritoneal mast cells.
Lau HY; Stenton GR
Inflamm Res; 1998; 47 Suppl 1():S22-3. PubMed ID: 9561398
[No Abstract] [Full Text] [Related]
15. The interaction of arginine 106 of human prostaglandin G/H synthase-2 with inhibitors is not a universal component of inhibition mediated by nonsteroidal anti-inflammatory drugs.
Greig GM; Francis DA; Falgueyret JP; Ouellet M; Percival MD; Roy P; Bayly C; Mancini JA; O'Neill GP
Mol Pharmacol; 1997 Nov; 52(5):829-38. PubMed ID: 9351974
[TBL] [Abstract][Full Text] [Related]
16. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 expression by nonsteroidal anti-inflammatory drugs in human airway smooth muscle cells: role of peroxisome proliferator-activated receptors.
Pang L; Nie M; Corbett L; Knox AJ
J Immunol; 2003 Jan; 170(2):1043-51. PubMed ID: 12517972
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase 2 expression by endothelin-1-stimulated mouse resident peritoneal macrophages in vitro.
Shimada K; Yonetani Y; Kita T; Suzumura A; Takayanagi T; Nakashima T
Eur J Pharmacol; 1998 Aug; 356(1):73-80. PubMed ID: 9761426
[TBL] [Abstract][Full Text] [Related]
19. NSAIDS inhibit the IL-1 beta-induced IL-6 release from human post-mortem astrocytes: the involvement of prostaglandin E2.
Blom MA; van Twillert MG; de Vries SC; Engels F; Finch CE; Veerhuis R; Eikelenboom P
Brain Res; 1997 Nov; 777(1-2):210-8. PubMed ID: 9449430
[TBL] [Abstract][Full Text] [Related]
20. Effect of nimesulide action time dependence on selectivity towards prostaglandin G/H synthase/cyclooxygenase activity.
Vago T; Bevilacqua M; Norbiato G
Arzneimittelforschung; 1995 Oct; 45(10):1096-8. PubMed ID: 8595067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
